Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.77 CAD | 0.00% | +0.87% | +11.18% |
22/03 | Knight Therapeutics Price Target Raised to $7 at RBC | MT |
21/03 | Knight Therapeutics Reports Fourth Quarter Results | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.18% | 425M | |
+12.55% | 9B | |
-12.75% | 4.96B | |
+42.38% | 4.47B | |
+5.23% | 3.9B | |
+20.51% | 2.45B | |
-19.05% | 2.41B | |
-28.72% | 2.23B | |
+11.13% | 2.02B | |
+3.94% | 1.65B |
- Stock Market
- Equities
- GUD Stock
- News Knight Therapeutics Inc.
- Knight Therapeutics : Says Health Canada Approves Neratinib for Treatment of HER2-Positive Breast Cancer